ANIP Stock Ownership Activity

ANI PHARMACEUTICALS INC 13F holders

1 value investing guru has made changes to the ANI PHARMACEUTICALS INC (ANIP) position according to the gurus' latest SEC quarterly report(s). ANIP has been bought (as a new position) by 1 guru(s)

Which gurus or hedge funds are buying ANIP now?

According to the latest SEC filing(s) ANI PHARMACEUTICALS INC (ANIP) has been bought by David M. Polen - Polen Capital Management (new buy).

To see more about who is investing in ANI PHARMACEUTICALS INC (ANIP), please go to the ANIP ownership page.

2026 Q1 (1 result)
David M. Polen
buy
+6,409
+0.00%
0.00%
Current price: $75.23 2.17% Reported price*: $76.90
2018 Q3 (1 result)
Bill Miller
-100.00%
-5,000
-0.01%
0.00%
Current price: $75.23 12.62% Reported price*: $66.80
2017 Q4 (1 result)
Bill Miller
buy
+5,000
+0.01%
0.01%
Current price: $75.23 16.82% Reported price*: $64.40
2017 Q3 (1 result)
Marty Whitman
-100.00%
-49,933
-0.11%
0.00%
Current price: $75.23 60.74% Reported price*: $46.80
2016 Q4 (1 result)
Marty Whitman
-0.24%
-120
-0.00%
0.14%
Current price: $75.23 24.10% Reported price*: $60.62
2015 Q4 (1 result)
Marty Whitman
-16.18%
-9,663
-0.01%
0.07%
Current price: $75.23 66.69% Reported price*: $45.13
2015 Q3 (1 result)
Marty Whitman
+15.30%
+7,926
+0.01%
0.06%
Current price: $75.23 90.44% Reported price*: $39.50
2015 Q2 (1 result)
Marty Whitman
buy
+51,790
+0.08%
0.08%
Current price: $75.23 21.22% Reported price*: $62.06
8 of 8

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.